Daito Pharmaceutical Co., Ltd. (4577)
Market Closed
10 Aug, 06:00
JPX JPX Primary 
TWSE ¥
1,276. 00
0
0%
¥
39.34B Market Cap
- P/E Ratio
40% Div Yield
62,900 Volume
- Eps
¥ 1,276
Previous Close Want to track 4577 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Daito Pharmaceutical Co., Ltd. (4577) Statistics
Valuation metrics
Market Cap 39.34B
Enterprise value 45.02B
Trailing P/E (ttm) 11.87
Forward P/E 5.8
PEG ratio 0.17
Price/Sales (ttm) 0.72
Price/Book (mrq) 0.7
Enterprise Value/Revenue 0.89
Enterprise Value/EBITDA 6.01
Overview
Shares outstanding 29.49M
Float 26.25M
Shares short -
% Held by insiders 0.15%
% Held by institutions 0.28%
Average volume (10 days) 64.08K
Average volume (90 days) 81.48K
Price summary
52-Week low 1,120
52-Week high 1,521
Beta 0.19
50-Day moving average 1,256.14
200-Day moving average 1,317.9
Dividends and splits
Forward annual dividend rate 40
Forward annual dividend yield 0.0321%
Trailing annual dividend rate 40
Trailing annual dividend yield 0.0313%
5-Year annual dividend yield 2.4%
Payout ratio 0.35
Dividend Date 5 Aug 2026
Ex-Dividend Date 28 May 2026
Last split factor 2:1
Last split Date 29 May 2025
Financials
Fiscal year
Fiscal year ends 31 May 2025
Most recent quarter (mrq) 31 Aug 2024
Profitability
Profit margin 0.06%
Operating margin 0.07%
Operational effectiveness
Return on assets 0.04%
Return on equity 0.06%
Income Statement
Revenue (ttm) 50.77B
Revenue per share (ttm) 1,752.96
Quarterly revenue growth (yoy) -0.04%
Gross profit (ttm) 9.38B
EBITDA 7.16B
Net income to common (ttm) 2.96B
Diluted EPS (ttm) 109.4
Quarterly earnings growth (yoy) 2.35%
Balance Sheet
Total cash (mrq) 1.87B
Total cash per share (mrq) 33.02
Total debt (mrq) 10.15B
Total Debt/Equity (mrq) 0.18
Current ratio (mrq) 2.62%
Book value per share (mrq) 1,832.32
Cash Flow
Cash flow statement 2.57B
Levered free cash flow (LFCF) 1.91B
